Securities Lawyer 101 l Brenda Hamilton

Securities Lawyer 101 l Brenda Hamilton

Monday, October 24, 2016

Robert Gadimian Charged with Insider Trading


The Securities and Exchange Commission ("SEC") today charged the former senior director of regulatory affairs for Puma Biotechnology with insider trading ahead of the company's news announcements about a drug to treat breast cancer. The SEC allege...
https://www.securitieslawyer101.com/?p=35946

No comments:

Post a Comment